Sheets Smith Wealth Management’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-11,115
Closed -$274K 313
2022
Q3
$274K Buy
+11,115
New +$367K 0.05% 253
2018
Q2
Sell
-13,267
Closed -$646K 310
2018
Q1
$646K Sell
13,267
-13,437
-50% -$672K 0.16% 161
2017
Q4
$1.34M Sell
26,704
-9,791
-27% -$513K 0.32% 83
2017
Q3
$1.85M Sell
36,495
-441
-1% -$20.8K 0.47% 61
2017
Q2
$1.4M Sell
36,936
-1,444
-4% -$57K 0.37% 78
2017
Q1
$1.48M Sell
38,380
-547
-1% -$16.5K 0.39% 78
2016
Q4
$860K Buy
+38,927
New +$799K 0.24% 115

Other funds holding CC

Sheets Smith Wealth Management's CC Position: Q4 2022 in Review

Sheets Smith Wealth Management sold out of Chemours (CC) in Q4 2022, closing a stake of 11,115 shares — an estimated $274K sold.

Sheets Smith Wealth Management first reported a position in CC in Q4 2016 and held it in 7 quarters. The position peaked at $1.85M in Q3 2017. 473 funds tracked by Wall St. Rank hold CC as of Q4 2022.

  • Sheets Smith Wealth Management reported no remaining Chemours position as of Q4 2022 after selling out during the quarter.
  • Sheets Smith Wealth Management sold 11,115 Chemours shares in Q4 2022, an estimated $274K.
  • Sheets Smith Wealth Management first reported a position in Chemours in Q4 2016 and held it in 7 quarters.
  • Sheets Smith Wealth Management's Chemours position peaked at $1.85M in Q3 2017.
  • 473 funds tracked by Wall St. Rank held Chemours as of Q4 2022.

Based on Sheets Smith Wealth Management's 13F filing for Q4 2022, filed 8 Mar 2023.